Production (Stage)
Glucose Health, Inc.
GLUC
$0.0905
-$0.0023-2.48%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | |||
|---|---|---|---|---|---|
| Revenue | 45.04% | 26.79% | -9.98% | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 45.04% | 26.79% | -9.98% | ||
| Cost of Revenue | 8.10% | 42.61% | -32.46% | ||
| Gross Profit | 148.06% | 2.97% | 19.28% | ||
| SG&A Expenses | -24.82% | -14.82% | 243.65% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | -9.30% | 7.66% | 79.48% | ||
| Operating Income | 106.15% | 28.05% | -1,718.64% | ||
| Income Before Tax | 106.15% | 28.70% | -1,936.54% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | 106.15% | 28.70% | -1,936.54% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | 106.15% | 28.70% | -1,936.54% | ||
| EBIT | 106.15% | 28.05% | -1,718.64% | ||
| EBITDA | -- | -- | -- | ||
| EPS Basic | 89.38% | 25.76% | -1,460.00% | ||
| Normalized Basic EPS | 106.78% | 28.57% | -1,533.33% | ||
| EPS Diluted | 89.38% | 25.76% | -1,460.00% | ||
| Normalized Diluted EPS | 106.78% | 28.57% | -1,533.33% | ||
| Average Basic Shares Outstanding | 0.00% | 0.00% | 19.10% | ||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 19.10% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | 17.28% | -0.30% | -1.06% | ||